Aspira Womens Health Inc (AWH)
3.39
-0.11
(-3.14%)
USD |
NASDAQ |
Apr 23, 16:00
3.40
+0.01
(+0.29%)
After-Hours: 20:00
Aspira Womens Health Cash from Financing (TTM): 5.216M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 5.216M |
September 30, 2023 | 4.161M |
June 30, 2023 | 7.624M |
March 31, 2023 | 7.442M |
December 31, 2022 | 7.427M |
September 30, 2022 | 7.51M |
June 30, 2022 | 0.017M |
March 31, 2022 | 0.274M |
December 31, 2021 | 48.38M |
September 30, 2021 | 51.16M |
June 30, 2021 | 62.13M |
March 31, 2021 | 68.23M |
December 31, 2020 | 20.15M |
September 30, 2020 | 17.33M |
June 30, 2020 | 8.154M |
March 31, 2020 | 15.42M |
December 31, 2019 | 15.44M |
September 30, 2019 | 15.44M |
June 30, 2019 | 13.45M |
March 31, 2019 | 13.33M |
December 31, 2018 | 13.30M |
September 30, 2018 | 13.29M |
June 30, 2018 | 16.87M |
March 31, 2018 | 3.329M |
December 31, 2017 | 8.486M |
Date | Value |
---|---|
September 30, 2017 | 8.49M |
June 30, 2017 | 4.915M |
March 31, 2017 | 6.928M |
December 31, 2016 | 1.824M |
September 30, 2016 | 1.963M |
June 30, 2016 | 19.51M |
March 31, 2016 | 16.26M |
December 31, 2015 | 15.10M |
September 30, 2015 | 25.45M |
June 30, 2015 | 8.028M |
March 31, 2015 | 9.354M |
December 31, 2014 | 10.53M |
September 30, 2014 | 17.86M |
June 30, 2014 | 17.78M |
March 31, 2014 | 30.05M |
December 31, 2013 | |
September 30, 2013 | |
June 30, 2013 | |
March 31, 2013 | |
December 31, 2012 | -5.888M |
September 30, 2012 | 0.012M |
June 30, 2012 | -4.988M |
March 31, 2012 | -4.942M |
December 31, 2011 | 15.24M |
September 30, 2011 | 15.23M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
0.017M
Minimum
Jun 2022
68.23M
Maximum
Mar 2021
19.74M
Average
13.45M
Median
Jun 2019
Cash from Financing (TTM) Benchmarks
Bruker Corp | -193.40M |
Azenta Inc | -452.51M |
Harvard Bioscience Inc | -12.13M |
Bionano Genomics Inc | 113.82M |
Akoya Biosciences Inc | 56.84M |